NCT05241470View on ClinicalTrials.gov

Study of ST-100 as Treatment for Dry Eye Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

October 11, 2021

Study Completion Date

October 11, 2021

Conditions
Dry Eye Disease
Interventions
DRUG

ST-100 Ophthalmic Solution

One drop in each eye twice a day

DRUG

Placebo Ophthalmic Solution

One drop in each eye twice a day

Trial Locations (3)

38119

Total Eye Care, P.A., Memphis

01810

Andover Eye Associates, Andover

02767

Andover Eye Associates - Raynham, Raynham

All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Stuart Therapeutics, Inc.

INDUSTRY